Product Name:Goserelin acetate
Synonyms:Fertilan
CAS No:1233494-97-7
Purity:95%
Molar Mass:1329.5
Chemical Formula:C61H88N18O16
Storage:Store at -20 degrees Celsius
Sequence:XHWSYXLRP
Application:
Goserelin acetate is a synthetic peptide analog of luteinizing hormone-releasing hormone (LHRH). It functions as a GnRH (gonadotropin-releasing hormone) analog and is used primarily in the treatment of hormone-sensitive cancers, such as prostate cancer and breast cancer, as well as in managing endometriosis and uterine fibroids. Goserelin acetate acts by suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland, leading to reduced levels of sex hormones (testosterone and estrogen). This suppression helps to slow the growth of hormone-dependent tumors and manage symptoms associated with hormone-driven conditions.
Current Research:
Goserelin acetate, a synthetic luteinizing hormone-releasing hormone (LHRH) agonist, continues to play a pivotal role in contemporary medical research, particularly in the fields of oncology, endocrinology, and reproductive health. As a potent analog of the naturally occurring gonadotropin-releasing hormone (GnRH), goserelin acetate effectively regulates the hypothalamic-pituitary-gonadal axis by desensitizing GnRH receptors through continuous stimulation. This results in the suppression of gonadotropin release, leading to a significant reduction in circulating sex hormone levels—a mechanism widely utilized in clinical settings.
In oncology, goserelin acetate is extensively studied for its utility in hormone-dependent cancers such as prostate and breast cancer. Recent investigations have focused on its role in combination therapies, exploring synergistic effects with novel chemotherapeutic agents and immunotherapies to enhance efficacy and minimize resistance. Additionally, its protective effect against chemotherapy-induced ovarian failure is under rigorous evaluation, offering a potential strategy to preserve fertility in premenopausal women undergoing cancer treatment.
In reproductive medicine, the compound’s application in assisted reproductive technologies (ART) is garnering attention. Studies are delving into its ability to optimize controlled ovarian hyperstimulation protocols, reduce the risk of ovarian hyperstimulation syndrome, and improve outcomes in patients with polycystic ovary syndrome (PCOS).
Emerging research also highlights the neuroendocrine implications of goserelin acetate, investigating its impact on brain regions associated with cognitive and emotional regulation. These studies aim to elucidate the potential long-term effects of LHRH analogs on neural function, an area of growing concern in chronic therapies.
Goserelin acetate remains a cornerstone in translational and clinical research, with ongoing trials aimed at expanding its therapeutic potential and understanding its multifaceted mechanisms. Researchers continue to leverage its biochemical properties to address complex medical challenges, ensuring its relevance in the advancement of science and medicine.
Reference:
Get a Quote
LinkPeptide
